Alcon Inc. Profile Avatar - Palmy Investing

Alcon Inc.

Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intra…
Medical - Instruments & Supplies
CH, Geneva [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 0% Bad
Profitability n.A. n.A.
Fin. Growth 33% Weak
Leverage & Liquidity 17% Weak
Per Share Metrics 67% Positive
Fin. Health n.A. n.A.
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 10.31 2.51 2.28
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 12.83 5.84 5.17
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 0.90 42.18 41.80
Cash 4.09 2.32 2.23
Capex 61.40 -0.29 -0.75
Free Cash Flow 80.77 0.40 0.22
Revenue -0.91 4.98 5.03
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 2.95 0.56 0.55
Operating Margin -18.33 0.15 0.18
ROA -41.84 < 0.005 0.01
ROE -42.51 0.01 0.02
ROIC -76.84 0.01 0.05
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ALC is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ALC is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ALC is permitted for members.
End of ALC's Analysis
CIK: 1167379 CUSIP: H01301128 ISIN: CH0432492467 LEI: - UEI: -
Secondary Listings